1477 (1477) News
Follow 1477 (1477) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
China Approves Ocumension Therapeutics Implant for Localized Production
Ocumension Therapeutics says China's NMPA approved its fluocinolone acetonide intravitreal implant for localized production.
EQUITY | Oct 27, 2026, 05:13 PM UTC
L
Makalot Industrial reports Aug revenue NT$3.55B vs NT$3.75B
Makalot Industrial Co. Ltd. revenue for Aug 2026 was NT$3,554,003,000 versus NT$3,745,640,000 in 2025. Jan-Aug revenue was NT$23,616,164,000 versus NT$24,139,451,000 in 2025. Source: Taiwan Stock Exchange.
EQUITY | Sep 02, 2026, 06:01 AM UTC
L
Ocumension Therapeutics NMPA accepts dexamethasone intraocular suspension application
Ocumension Therapeutics said its dexamethasone intraocular suspension application was accepted by NMPA.
EQUITY | Sep 01, 2026, 03:57 PM UTC
M
Ocumension Therapeutics posts HY adjusted net loss of RMB57.5M
Ocumension Therapeutics reported HY adjusted net loss of RMB57.5 million.
EQUITY | Aug 28, 2026, 03:27 PM UTC
L
Ocumension Therapeutics H1 revenue jumps on higher ophthalmic sales
Ocumension Therapeutics said its H1 revenue surged, citing higher ophthalmic product sales.
GEOPOLITICS | Aug 28, 2026, 02:24 PM UTC